Back to Search Start Over

Treatment-Resistant Human Extraparenchymal Neurocysticercosis: An Immune-Inflammatory Approach to Cysticidal Treatment Outcome.

Authors :
Arce-Sillas A
Cárdenas G
Álvarez-Luquín D
Hernandez M
Del Rey A
Besedovsky H
Gómez-Fuentes S
Fragoso G
Fleury A
Sciutto E
Adalid-Peralta L
Source :
Neuroimmunomodulation [Neuroimmunomodulation] 2018; Vol. 25 (2), pp. 103-109. Date of Electronic Publication: 2018 Jul 24.
Publication Year :
2018

Abstract

Objective: The aim of this study is to analyze the immune-endocrine profile in neurocysticercosis (NC) patients resistant to cysticidal treatment.<br />Methods: The inflammatory and regulatory responses of 8 resistant NC patients with extraparenchymal parasites and 5 healthy controls were evaluated through flow cytometry. Serum interleukin levels were measured by ELISA and catecholamines levels by high performance liquid chromatography.<br />Results: Higher percentages of Tr1, CD4+CD25+FOXP3+CD127- and CD4+CD45RO+FOXP3HI were found in NC patients compared with healthy controls, but no difference was found in catecholamine levels. Antigen-specific proliferative immune response was observed in NC patients. Neither anti-inflammatory nor pro-inflammatory cytokines showed differences between patients and controls, but IL-6 levels were lower in treatment-resistant NC patients. In addition, TGFβ showed a significant negative correlation with dopamine.<br />Conclusions: Altogether, these results may point to a modulation of the neuroinflammation in these patients that could indirectly favor cysticercal survival in CNS microenvironment.<br /> (© 2018 S. Karger AG, Basel.)

Details

Language :
English
ISSN :
1423-0216
Volume :
25
Issue :
2
Database :
MEDLINE
Journal :
Neuroimmunomodulation
Publication Type :
Academic Journal
Accession number :
30041237
Full Text :
https://doi.org/10.1159/000491394